title: When should surveillance imaging be performed after treatment for head and neck cancer?
authors.affiliation: Department of Head and Neck Surgery, University of California, Los Angeles, California, U.S.A.
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Heineman
authors.affiliation: Department of Head and Neck Surgery, University of California, Los Angeles, California, U.S.A.
authors.forename: Edward C
authors.initials: EC
authors.lastname: Kuan
authors.affiliation: Department of Head and Neck Surgery, University of California, Los Angeles, California, U.S.A.|Jonsson Comprehensive Cancer Center, UCLA Medical Center, Los Angeles, California, U.S.A.|UCLA Head and Neck Cancer Program, UCLA Medical Center, Los Angeles, California, U.S.A.
authors.forename: Maie A
authors.initials: MA
authors.lastname: St John
mesh_terms: D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging*; D018365:Neoplasm, Residual / Q000175:diagnosis*; D000072078:Positron Emission Tomography Computed Tomography; D017410:Practice Guidelines as Topic; D013997:Time Factors